1. Italy Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
EL.En. S.p.A.

EL.En. S.p.A.

ELEAF
EL.En. S.p.A.US flagOther OTC
15.94
USD
- -
- -
1.28BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
2.04
2.33
2.82
3.27
3.97
4.48
5.2
5.24
7.17
8.43
7.21
7.02
7.35
7.44
Basic EPS, GAAP
0.08
0.21
0.19
0.52
0.2
0.22
0.34
0.26
0.57
0.69
0.6
0.64
0.54
0.42
Free Cash Flow per Basic Share
0.14
0.19
0.11
0.25
0.17
-0.19
0.21
0.36
0.79
-0.2
-0.01
1.03
0.88
- -
Dividend per Share
0.05
0.04
0.07
0.08
0.12
0.11
0.11
- -
0.12
0.22
0.24
0.21
0.23
- -
Book Value per Share
0.51
0.7
0.58
1.02
0.69
0.91
1.21
1.14
1.69
2.15
2.38
2.65
2.79
- -
Tangible Book Value per Share
1.7
1.9
2.28
2.44
2.59
2.78
3.06
3.03
3.55
4.13
4.54
5.04
5.26
- -
Basic Weighted Avg Shares
77
77
77
77
77
77
77
78
80
80
80
81
80
80
Sales/Revenue/Turnover
157
180
218
253
306
346
401
408
571
674
576
566
591
596
Operating Margin (%)
5.05
7.38
9.04
9.79
8.67
7.15
8.76
6.05
10.38
11.18
12.81
12.69
12.22
12.26
Depreciation Expense
3
3
3
4
4
4
7
8
9
10
9
12
10
7
Net Income, GAAP
6
17
14
40
16
17
26
20
45
55
48
52
43
33
Effective Tax Rate (%)
39.98
26.26
30.56
18.45
25.01
26.08
25.54
19.27
26.04
25.26
29.04
25.24
31.64
- -
Profit Margin (%)
3.86
9.18
6.6
15.99
5.1
4.85
6.49
4.96
7.95
8.18
8.37
9.12
7.35
5.59
Working Capital
77
103
95
141
154
155
162
173
212
240
267
467
345
- -
LT Debt
7
6
5
4
6
12
21
31
37
38
29
23
17
- -
Total Equity
134
151
180
193
204
219
241
241
288
343
375
411
427
- -
Return on Invested Capital (%)
3.22
5.95
7.27
9.91
9.35
7.99
10.06
6.93
13.5
14.33
11.89
11.87
10.71
- -
Return on Capital (%)
8.83
19.74
16.17
42.88
11.86
12.39
18.19
11.78
22.53
20.68
16.29
17.83
15.33
22.7
Return on Common Equity (%)
15.94
35.23
29.01
65.12
23.61
27.26
31.96
22.25
40.63
36.03
26.66
25.54
19.82
- -

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
21
- -
LT Borrowings
- -
6
- -
LT Finance Leases
- -
11
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
80
80
80
Market Capitalization
854
853
1,151

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
- -
509
- -
Cash, Cash Equivalents & STI
- -
211
- -
Accounts Receivable, Net
- -
117
- -
Inventories
- -
157
- -
Total Current Liabilities
- -
164
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
21
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
9.21%
12.34%
4.06%
Free Cash Flow
-770.46%
-1,492.79%
-14.75%
Net Income, GAAP
28.43%
24.85%
-15.88%
Sales/Revenue/Turnover
11.4%
9.21%
4.42%
Total Cash Common Dividend
824.31%
1,656.87%
9.81%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
130
160
135
100
566
2025
141
144
137
169
591
2026
146
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.2
- -
0.24
- -
0.64
2025
0.2
- -
0.26
- -
0.54
2026
0.25
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.21
2025
- -
- -
- -
- -
0.23
2026
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Gabriele Clementi
Full Time Employees
2,080
Sector
Healthcare
Industry
Medical - Devices
Address
Via Baldanzese 17 Calenzano FI Italy 50041
IPO Date
Apr 12, 2012
Website
elengroup.com
Similar Companies
Accuray Incorporated (ARAY)
Nexalin Technology, Inc. (NXL)
Promimic AB (publ) (PRO.ST)
Dynatronics Corporation (DYNTQ)
Codex DNA, Inc. (DNAY)
ZimVie Inc. (ZIMV)
Business
EL.En. S.p.A. (ELEAF) leads an international group specializing in the research, development, production, and sale of advanced laser systems and solutions for medical, industrial, and art conservation applications; its medical segment provides laser equipment for dermatology, surgery, aesthetics, physiotherapy, dentistry, urology, gynecology, and body shaping, including proprietary platforms such as the PRO line with Onda PRO microwave devices for non-invasive cellulite and adiposity treatments, RedTouch PRO for collagen stimulation at 675 nm, and high-power alexandrite lasers for hair removal; the industrial segment offers CO2 and fiber lasers, galvo scanners, and systems for cutting, marking, welding, engraving metals, wood, plastics, glass, leather, fabrics, and paper; the conservation segment delivers laser cleaning technologies for restoring artworks. Founded in 1981 and headquartered in Calenzano near Florence, Italy, the group operates globally through 14 companies across Europe, America, and Asia, serving professionals, industries, and cultural institutions with certified, environmentally respectful products that minimize waste, fumes, and chemicals. In 2025, EL.En. acquired a majority stake in Nexam Chemical at the beginning of the year to bolster its marking capabilities, disposed of its Chinese subsidiary Withus (retaining a 33% equity stake accounted via equity method) and sold a majority stake in Pentalis to improve its net financial position amid macroeconomic challenges, expanded European operations via subsidiaries like LASIT and Cutlite Penta, reported H1 consolidated revenues of EUR 285.3 million (up 5.1% year-over-year) with positive net income of EUR 17.9 million, and advanced mid-power CO2 laser sources and scanning units while confirming full-year revenue growth targets.

Company News

APIChat

  • seekingalpha.com

    EL.En. S.p.A. (ELEAF) Q1 2026 Earnings Call Transcript

  • seekingalpha.com

    EL.En. S.p.A. (ELEAF) Q4 2025 Earnings Call Transcript

  • seekingalpha.com

    EL.En. S.p.A. (ELEAF) Q3 2025 Earnings Call Transcript